FindTrial
Sign In

Clopidogrel and Aspirin

DRUG3 trials

Sponsors

China National Center for Cardiovascular Diseases, Chong Kun Dang Pharmaceutical, Beijing Tiantan Hospital

Conditions

AtherosclerosisCoronary Artery DiseaseStrokeTransient Ischemic Attack

Phase 1

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial
CompletedNCT01496261
Chong Kun Dang PharmaceuticalCoronary Artery Disease
Start: 2011-08-31End: 2011-09-30Updated: 2011-12-21

Phase 3

The Clopidogrel and Aspirin After Surgery for Coronary Artery Disease
NCT00776477
China National Center for Cardiovascular DiseasesAtherosclerosis
Start: 2007-12-31Target: 300Updated: 2008-10-21
Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II
CompletedNCT04078737
Beijing Tiantan HospitalStroke, Transient Ischemic Attack
Start: 2019-09-23End: 2021-07-01Updated: 2021-12-02

Related Papers

Effect of insulin resistance on ticagrelor-versus clopidogrel-based dual antiplatelet therapy for secondary prevention of stroke in carriers of <i>CYP2C19</i> loss-of-function mutations.
2026-01-18
Lp-PLA2 Activity and Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack.
2026-01-13
Differential Effect of Ticagrelor Versus Clopidogrel by Causative Classification of Stroke Classification and Vascular Cellular Adhesion Molecule-1 Level on the Risk of Recurrent Stroke: A Post Hoc Analysis of the CHANCE-2 Trial.
2025-12-18
Dual antiplatelet therapy with ticagrelor vs clopidogrel in patients with TIA or minor stroke with or without symptomatic carotid artery stenosis: a post hoc analysis of the CHANCE-2 trial.
2025-10-272 citations
Genotype-guided dual antiplatelet therapy in minor stroke or transient ischemic attack with metabolic syndrome: A post hoc analysis of CHANCE-2.
2025-10-27
PCISOS Risk Profiles Stratify Heterogeneous Outcomes in Minor Posterior Circulation Ischemic Stroke: A Post Hoc Analysis of the CHANCE-2 Trial
Stroke2025-09-10
Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial.
2024-11-053 citations
Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source: A Subgroup Analysis of the CHANCE-2 Trial
Stroke2024-06-113 citations
Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial
Canadian Medical Association Journal2024-02-115 citations
One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in <i>CYP2C19</i> Loss-of-Function Carriers With Stroke or TIA Trial.
2024-01-053 citations
Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in <i>CYP2C19</i> loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trial.
2023-12-021 citations
Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE‐2
Journal of the American Heart Association2023-10-2712 citations
Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial
Stroke2023-08-0715 citations
Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack
Canadian Medical Association Journal2023-07-096 citations
Association of <i>CYP2C19</i> Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin
JAMA Network Open2023-06-069 citations
Stroke Recurrence and Antiplatelets in Posterior Versus Anterior Circulation Minor Stroke or Transient Ischemic Attack
Stroke2023-03-2716 citations
Ticagrelor Aspirin vs Clopidogrel Aspirin in <i>CYP2C19</i> Loss-of-Function Carriers With Minor Stroke or TIA Stratified by Risk Profile
Neurology2022-12-1914 citations
Ticagrelor-Aspirin Versus Clopidogrel-Aspirin Among <i>CYP2C19</i> Loss-of-Function Carriers With Minor Stroke or Transient Ischemic Attack in Relation to Renal Function: A Post Hoc Analysis of the CHANCE-2 Trial.
2022-11-019 citations
Effect of Hypertension on Efficacy and Safety of Ticagrelor-Aspirin Versus Clopidogrel-Aspirin in Minor Stroke or Transient Ischemic Attack
Stroke2022-06-038 citations
Ticagrelor versus Clopidogrel in <i>CYP2C19</i> Loss-of-Function Carriers with Stroke or TIA
New England Journal of Medicine2021-10-28350 citations

2 more papers not shown